Global PRMT5 Targeted Therapy Market & Clinical Trials Opportunity Outlook 2024: PRMT5 Targeted Therapies Clinical Trials by Company, Indication & Phase
DUBLIN, Feb. 28, 2024 /PRNewswire/ — The “Global PRMT5 Targeted Therapy Market & Clinical Trials Opportunity Outlook 2024” report has been added to ResearchAndMarkets.com’s offering. A comprehensive study, delineating the pioneering developments in the realm of PRMT5 (
Europe Nucleic Acid Therapeutics CDMO Market Research Report 2024
DUBLIN, Feb. 28, 2024 /PRNewswire/ — The “Europe Nucleic Acid Therapeutics CDMO Market: Analysis and Forecast, 2023-2033” report has been added to ResearchAndMarkets.com’s offering. The Europe nucleic acid therapeutics CDMO market was valued at $1.27 billion in 2023 and is
RDP Partnered with Bongards to Expand Farmer Opportunities in America’s Heartland
PERHAM, Minn., Feb. 28, 2024 /PRNewswire/ — Rural Development Partners (RDP) was pleased to award Bongards Creameries $20 million in New Markets Tax Credit financing for equipment toward the expansion of their cheese and whey processing facility in Perham, Minnesota. The funding will allow Bo
LOBLAW COMPANIES LIMITED TO ISSUE $400 MILLION OF SENIOR UNSECURED NOTES
BRAMPTON, ON, Feb. 28, 2024 /CNW/ – (TSX: L) – Today, Loblaw Companies Limited (“Loblaw” or the “Company”) announced that it has agreed to issue, on a private placement basis to qualified accredited investors in each of the Provinces of Canada, $400 million aggrega
Humane Announces Strategic Partnership with SoftBank to Transform AI Experience in Japan
BARCELONA, Spain, Feb. 29, 2024 /PRNewswire/ — In a further announcement at Mobile World Congress, Humane Inc today revealed plans for a Telco partnership with SoftBank Corp.(SoftBank) for the Humane Ai Pin, the first stand-alone Ai device and proprietary Ai-driven OS, CosmOS. This partnership
Reporting of transactions made by persons discharging managerial responsibilities
SUGAR LAND, Texas, Feb. 28, 2024 /PRNewswire/ — Noble Corporation plc (“Noble”) (CSE: NOBLE, NYSE: NE) today announces that the persons listed below (the “PDMRs”) have conducted transactions in the A ordinary shares of Noble each with a nominal value of USD 0.00001. F
EQB delivers 12% y/y earnings growth, increases dividend 5% q/q and 20% y/y, with assets under management and administration climbing 16% to $119 billion
TORONTO, Feb. 28, 2024 /PRNewswire/ – EQB Inc. (TSX: EQB) (TSX: EQB.PR.C) today reported earnings for the three months ended January 31, 2024, that reflected strong and resilient first quarter performance driven by growth in loans under management, margin expansion, higher non-interest revenue
Spin Master Reports Fourth Quarter and Full Year 2023 Financial Results
TORONTO, Feb. 28, 2024 /PRNewswire/ – Spin Master Corp. (“Spin Master” or the “Company”) (TSX: TOY; www.spinmaster.com), a leading global children’s entertainment company, today announced its financial results for the three months and year ended December 31, 2023.
ALIMENTATION COUCHE-TARD TO RELEASE RESULTS FOR ITS THIRD QUARTER OF ITS FISCAL YEAR 2024 ON MARCH 20, 2024
LAVAL, QC, Feb. 28, 2024 /PRNewswire/ – Alimentation Couche-Tard Inc. (“Couche-Tard” or the “Corporation”) (TSX: ATD) will release financial results for its third quarter of its fiscal year 2024 on Wednesday, March 20, 2024, after the closing of the TSX. Couche-Tard wi
Stoneridge Reports Fourth Quarter 2023 Results
Achieves Q4 Sequential EPS Improvement In Line with Prior Expectations Establishes 2024 Midpoint Revenue Guidance of $1 Billion And Midpoint EBITDA of $67 Million (Midpoint EBITDA Margin Expansion Of 170 Basis Points vs. 2023) Maintains 2027 Long-Term Target and Establishes 2028 Revenue Target of $1
